Brentuximab vedotin in patients aged 60 years or older with relapsed or refractory CD30-positive lymphomas: a retrospective evaluation of safety and efficacy

✍ Scribed by Gopal, Ajay K.; Bartlett, Nancy L.; Forero-Torres, Andres; Younes, Anas; Chen, Robert; Friedberg, Jonathan W.; Matous, Jeffrey V.; Shustov, Andrei R.; Smith, Scott E.; Zain, Jasmine; O’Meara, Megan M.; Fanale, Michelle A.

• Book ID: 124075851
• Publisher: Informa plc
• Year: 2014
• Tongue: English
• Weight: 156 KB
• Volume: 55
• Category: Article
• ISSN: 1042-8194
• DOI: 10.3109/10428194.2013.876496